UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
|
ý |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
|
For the quarterly period ended September 27, 2003 |
|
|
|
|
|
OR |
|
|
|
|
|
o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the transition period from to
Commission file number 000-18032
LATTICE SEMICONDUCTOR CORPORATION
(Exact name of Registrant as specified in its charter)
|
State of Delaware |
|
93-0835214 |
|
(State or other
jurisdiction |
|
(I.R.S. Employer |
|
|
|
|
|
5555 N.E. Moore Court, Hillsboro, Oregon |
|
97124-6421 |
|
(Address of principal executive offices) |
|
(Zip Code) |
|
|
|
|
|
(503) 268-8000 |
||
|
(Registrants telephone number, including area code) |
||
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes ý No o
At September 27, 2003, there were 112,772,007 shares of the Registrants common stock, $.01 par value, outstanding.
LATTICE SEMICONDUCTOR CORPORATION
INDEX
2
PART I. FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
LATTICE SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(In thousands, except per share data)
(unaudited)
|
|
|
Three Months Ended |
|
Nine Months Ended |
|
||||||||
|
|
|
Sept. 30, |
|
Sept. 30, |
|
Sept. 30, |
|
Sept. 30, |
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Revenue |
|
$ |
51,038 |
|
$ |
56,072 |
|
$ |
167,527 |
|
$ |
171,416 |
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Costs and expenses: |
|
|
|
|
|
|
|
|
|
||||
|
Cost of products sold |
|
20,662 |
|
22,429 |
|
67,159 |
|
68,527 |
|
||||
|
Research and development |
|
21,173 |
|
21,523 |
|
64,707 |
|
63,986 |
|
||||
|
Selling, general and administrative |
|
12,114 |
|
11,712 |
|
37,211 |
|
35,790 |
|
||||
|
In-process research and development |
|
|
|
5,653 |
|
|
|
29,853 |
|
||||
|
Amortization of intangible assets (1) |
|
18,665 |
|
18,070 |
|
58,466 |
|
54,616 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Total costs and expenses |
|
72,614 |
|
79,387 |
|
227,543 |
|
252,772 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Loss from operations |
|
(21,576 |
) |
(23,315 |
) |
(60,016 |
) |
(81,356 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Other (expense) income, net |
|
(3,611 |
) |
2,764 |
|
(3,485 |
) |
3,941 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Loss before benefit for income taxes |
|
(25,187 |
) |
(20,551 |
) |
(63,501 |
) |
(77,415 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Benefit for income taxes |
|
(3,300 |
) |
(6,180 |
) |
(5,854 |
) |
(29,280 |
) |
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Net loss |
|
$ |
(21,887 |
) |
$ |
(14,371 |
) |
$ |
(57,647 |
) |
$ |
(48,135 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic net loss per share |
|
$ |
(0.20 |
) |
$ |
(0.13 |
) |
$ |
(0.52 |
) |
$ |
(0.44 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Diluted net loss per share |
|
$ |
(0.20 |
) |
$ |
(0.13 |
) |
$ |
(0.52 |
) |
$ |
(0.44 |
) |
|
|
|
|
|
|
|
|
|
|
|
||||
|
Shares used in per share calculations: |
|
|
|
|
|
|
|
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Basic |
|
111,840 |
|
110,232 |
|
111,615 |
|
109,855 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Diluted |
|
111,840 |
|
110,232 |
|
111,615 |
|
109,855 |
|
||||
(1) Includes $820 and $760 of amortization of deferred stock compensation expense for the three months ended September 30, 2003 and September 30, 2002, respectively, and $4,931 and $1,887 for the nine months ended September 30, 2003 and September 30, 2002, respectively, attributable to Research and Development activities.
See Accompanying Notes to Condensed Consolidated Financial Statements
3
LATTICE SEMICONDUCTOR CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEET
(In thousands, except share and par value data)
(unaudited)
|
|
|
Sept. 30, |
|
December 31, |
|
||
|
Assets |
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
153,334 |
|
$ |
169,475 |
|
|
Short-term investments |
|
125,420 |
|
107,405 |
|
||
|
Accounts receivable, net |
|
26,941 |
|
26,374 |
|
||
|
Inventories |
|
47,942 |
|
56,241 |
|
||
|
Other current assets |
|
12,617 |
|
35,033 |
|
||
|
|
|
|
|
|
|||